Therapeutic Areas: Gastroenterology | Oncology | Hepatology (Liver, Pancreatic, Gall Bladder)

Digestive System Neoplasms Clinical Trials


A listing of Digestive System Neoplasms medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Arizona

Phoenix : Mayo Clinic Arizona

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Scottsdale : Virginia G. Piper Cancer Center at Scottsdale Healthcare

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

Connecticut

New Haven : Yale Cancer Center

A clinical trial to evaluate treatments using Sorafenib, Capecitabine for patients with Metastatic Breast Cancer or Gastrointestinal Tumors

District of Columbia

Washington : DC Endoscopy Center

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Florida

Boca Raton : Lynn Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Fort Myers : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Gainesville : University of Florida

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Miami : University of Miami

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Orlando : Florida Hospital Cancer Institute Memorial System

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

St. Petersburg : Florida Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Illinois

Arlington Heights : Illinois Cancer Specialists

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Chicago : Rush University Medical Center

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Chicago : University of Chicago Medicine

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Evanston : NorthShore University Health System

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Evanston : Northshore University Healthsystem Research Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Louisiana

Baton Rouge : Gastroenterology Associates, LLC

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Maryland

Baltimore : Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Chevy Chase : Chevy Chase Endoscopy Center

A clinical trial seeking patients for a research study for the treatment of Colorectal Neoplasms or Colorectal Cancer

Chevy Chase : MGG Group, Co. Inc./Chevy Chase Clinical Research

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Michigan

Detroit : Karmanos Cancer Institute

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Farmington Hills : Detroit Clinical Research Center, PC

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Minnesota

Minneapolis : University of Minnesota Masonic Cancer Clinic

Patients are needed to participate in a clinical research study evaluating Minnelide™ 001 for the treatment of Advanced Gastrointestinal Tumors

Rochester : Mayo Clinic

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Missouri

Mexico : Center for Digestive and Liver Diseases, Inc

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

New York

New York : Memorial Sloan-Kettering Cancer Center

A clinical research study of TAS-102 and CPT-11 for the treatment of Advanced Gastrointestinal Tumors

New York : Mount Sinai School of Medicine

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

New York : Columbia University Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Rochester : University of Rochester Medical Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

North Carolina

Asheville : Asheville Gastroeneterology Associates

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Ohio

Cincinnati : Oncology Hematology Care Inc.

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Columbus : Ohio State University Comprehensive Cancer Center

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Oregon

Portland : Oregon Health and Sciences University

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Pennsylvania

Philadelphia : University of Pennsylvania

A Phase 2 clinical study for patients with Metastatic Pancreatic Cancer

Tennessee

Chattanooga : Tennessee Oncology - Chattanooga

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Nashville : Tennessee Oncology PLLC

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Texas

Fort Worth : Center for Cancer and Blood Disorders

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Virginia

Lynchburg : Blue Ridge Medical Research

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Washington

Seattle : Swedish Medical Center Cancer Institute

A clinical research study of AUY922 and Cetuximab

Wisconsin

Madison : University of Wisconsin Hospital and Clinics

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Milwaukee : Wisconsin Center for Advanced Research

A clinical trial to evaluate treatments for patients with Inflammatory Bowel Disease (IBD), Primary Sclerosing Cholangitis (PSC), Colorectal Neoplasms or Colorectal Cancer

Australia

South Brisbane : Icon Cancer Care South Brisbane

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Belgium

Brussels : Hôpital Erasme

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Canada

Edmonton : Cross Cancer Institute

A clinical research study of Irinotecan-Capecitabine-Oxaliplatin for the treatment of Gastrointestinal Neoplasm or Gastric Adenocarcinoma

Korea, Republic of

Anyang : Hallym University Medical Center

A clinical trial seeking patients for a research study for the treatment of Gastrointestinal Neoplasms

Malaysia

Kuala Lumpur : University Malaya Medical Centre

A clinical research study of ThermoDox for the treatment of Hepatocellular Carcinoma

Spain

Barcelona : Hospital Universitario Vall d'Hebron

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Centro Integral Oncologico Clara Campal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario Ramon y Cajal

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Madrid : Hospital Universitario 12 de Octubre

A Phase 3 clinical study for patients using nab-Paclitaxel 125 mg/m2 and gemcitabine 1000 mg/m2

Sweden

Göteborg : Sahlgrenska University Hospital

A clinical trial seeking patients for a research study for the treatment of Rectal Cancer

Switzerland

Berne : Department of visceral surgery and transplant surgery, Berne University Hospital

A Phase 4 clinical study for patients with Malnourishment or Gastrointestinal Tumors